Compounds, compositions containing them, preparation thereof...

Details Compounds, compositions containing them, preparation thereof... Compounds, compositions containing them, preparation thereof...

2006-05-22

2009-06-23

Anderson, Rebecca L (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S304400

Reexamination Certificate

active

07550495

ABSTRACT:
Compounds of Formula I, or pharmaceutically acceptable salts thereof:wherein R1, R2, R3, R4, R5, and G are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

REFERENCES:
patent: 5482956 (1996-01-01), Lunkenheimer et al.
patent: 6166219 (2000-12-01), Yamasaki et al.
patent: 6348032 (2002-02-01), Sperl et al.
patent: 6352985 (2002-03-01), Yamasaki et al.
patent: 6376515 (2002-04-01), Zhu et al.
patent: 6534535 (2003-03-01), Zhu et al.
patent: 6632815 (2003-10-01), Zhu et al.
patent: 6686368 (2004-02-01), Zhu et al.
patent: 6720317 (2004-04-01), Song et al.
patent: 6835739 (2004-12-01), Zhu et al.
patent: 6844367 (2005-01-01), Zhu et al.
patent: 7030139 (2006-04-01), Cheng et al.
patent: 7115645 (2006-10-01), Halfbrodt et al.
patent: 2002/0006948 (2002-01-01), Halfbrodt et al.
patent: 2002/0082280 (2002-06-01), Sperl et al.
patent: 2004/0116465 (2004-06-01), Cheng et al.
patent: 2006/0052421 (2006-03-01), Welter et al.
patent: 2006/0094750 (2006-05-01), Kon-I et al.
patent: 2007/0072853 (2007-03-01), Liu et al.
patent: 2007/0082899 (2007-04-01), Page et al.
patent: 2007/0225346 (2007-09-01), Bohlin
patent: 2007/0244092 (2007-10-01), Brown et al.
patent: 0597304 (2001-01-01), None
patent: 0583665 (2003-03-01), None
patent: 1403255 (2004-03-01), None
patent: 5354 (1967-09-01), None
patent: 1604908 (1972-06-01), None
patent: 9411349 (1994-05-01), None
patent: 9411350 (1994-05-01), None
patent: 9724334 (1997-07-01), None
patent: 0112600 (2001-02-01), None
patent: 0119798 (2001-03-01), None
patent: 0151473 (2001-07-01), None
patent: 0151473 (2001-07-01), None
patent: 0200651 (2002-01-01), None
patent: 0246168 (2002-06-01), None
patent: 02085866 (2002-10-01), None
patent: 02085866 (2002-10-01), None
patent: 2004085385 (2004-10-01), None
patent: 2004108688 (2004-12-01), None
patent: 2004108712 (2004-12-01), None
patent: 2004108712 (2004-12-01), None
patent: 2005007625 (2005-01-01), None
patent: 2005021547 (2005-03-01), None
patent: 2005021547 (2005-03-01), None
patent: 2005030732 (2005-04-01), None
patent: 2005030732 (2005-04-01), None
patent: 2005030733 (2005-04-01), None
patent: 2005030733 (2005-04-01), None
patent: 2005030761 (2005-04-01), None
patent: 2005030761 (2005-04-01), None
patent: 2005030762 (2005-04-01), None
patent: 2005113542 (2005-12-01), None
patent: 2006009876 (2006-01-01), None
patent: 2006012642 (2006-02-01), None
patent: 2006033627 (2006-03-01), None
patent: 2006033628 (2006-03-01), None
patent: 2006033629 (2006-03-01), None
patent: 2006033630 (2006-03-01), None
patent: 2006033630 (2006-03-01), None
patent: 2006033632 (2006-03-01), None
patent: 2006033633 (2006-03-01), None
patent: 2006033633 (2006-03-01), None
patent: 2006048754 (2006-05-01), None
patent: 2006078941 (2006-07-01), None
patent: 2007108754 (2007-09-01), None
patent: 2007120101 (2007-10-01), None
Holenz Jorg et al., “Medicinal Chemistry Driven Approaches Toward Novel and Selective Serotonin 5-HT6 Receptor Ligands,” J. Med. Chem. 2005, vol. 48, pp. 1781-1795, table 1, compound 16.
Restriction Requirement issued for U.S. Appl. No. 11/689,864 on Mar. 24, 2008.
Final Rejection issued for U.S. Appl. No. 11/689,864 on Jan. 8, 2009.
Chawla et al., “Challenges in Polymorphism of Pharmaceuticals,” Crips, vol. 5(1), Jan.-Mar. 2004, pp. 9-12.
Newman et al., “Solid-state analysis of the active pharmaceutical ingredient in drug products,” Drug Discovery Today, vol. 8(19), Oct. 2003, pp. 898-905.
Evans et al., “Synthesis of a group of 1H-benzimidazoles and their screening for antiinflammatory activity,” Eur J Med Chem, 1996, vol. 31, pp. 635-642, example 27.
Holenz et al., “Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands,” J. Med. Chem., 2005, vol. 48, pp. 1781-1795, table 1, compound 16, abstract.
Li et al., “Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 2: Benzimidazole-5-sulfonamides,” Bioorganic & Medicinal Chemistry Letters, 2005, 15(3), pp. 805-807.
STN International, File CAPLUS, accession No. 1972:419030, doc. No. 77:19030, Koshienko et al., “Benzo(1,2-d:3,4-d′)diimidazole derivatives. II. Behavior of 3,6-dimethyl-and 3,6,7-trimethylbenzo(1,2-d:3,4-d′)diimidazole toward nucleophilic agents,” Khimiya Geterotsiklicheskikh Soedinenii, 1971, 7(8), pp. 1132-1135; XP002307925.
STN Intnl, File CHEMCATS, access No. 2003:1839419, “Benzenesulfonamide, N-(1,2-dimethyl-1H-benzimidazol-5-yl)-”, CAS Reg No. 488708-12-9; & STN Intnl, File CHEMCATS, access No. 2003:2399372, “Benzenesulfonamide, N-(2-methyl-1-(phenylmethyl)-1H-benzimidazol-5-yl-”, CAS Registry No. 488841-64-1; & STN Intnl, File CHEMCATS, access No. 2003:2595844, “Benzenesulfonamide, 4-methyl-N-(2-methyl-1-(phenylmethyl)-1H-benzimidazole-5-yl)-”, CAS Reg. No. 312617-94-0, 2002.
STN Intnl, File CHEMCATS, accession No. 2003:1839419, “Benzenesulfonamide, N-(1,2-dimethyl-1H-benzimidazol-5-yl)-” CAS Registry No. 488708-12-9; & STN Intnl, File CHEMCATS, accession No. 2003:1845322, “Benzenesulfonamide, 4-bromo-N-(1,2-dimethyl-1H-benzimidal-5-yl)-”, CAS Registry No. 489397-82-2; & STN Intnl. File CHEMCATS, accession No. 2003:2305521, “Benzenesulfonamide, N-(1,2-dimethyl-1H-benzimidazol-5-yl)-1-fluoro-”, CAS Registry No. 503429-33-2, 2002.
STN Intnl, file Registry, see RN: 848855-83-4, 2005.
STN Intnl, File CAPLUS, accession No. 1975:408737, doc No. 83:8737, Bieksa, V. et al., “Relation of the reactivity of chloroethyl derivatives of 3,4-diaminobenzenesulfopiperidides to the structure of alkylating group”, Lietuvos TSR Mokslu Akademijos Darbai, Serija B: Chemija, Technika, Fizine Geografija, (1974), (3) 91-8.
STN Intnl, File CAPLUS, accession No. 1973:515496, doc No. 79:115496, Bieksa, V. et al. “Chloroalkyl derivatives of benzimidazoles. 1. Chloroethyl derivatives of 2-methylbenzimidazole-5-sulfonamide,” Lietuvos TSR Mokslu Akademijos Darbai, Serija B: Chemija, Technika, Fizine Geografija, (1973), (2), 93-103.
ISR issued for PCT/SE2005/001403 on Dec. 14, 2005.
English abstract for EP 0597304, 2001.
English abstract for FR 1604908, 1972.
English abstract for FR 5354M, 1967.
English abstract for WO 9411349, 1994.
English abstract for WO 9411350, 1994.
English abstract for WO 9724334, 1997.
English abstract for WO 0151473, 2001.
Non-Final Office Action issued for U.S. Appl. No. 11/689,864 on Jul. 9, 2008.
Brittain et al., “Effects of Pharmaceutical Processing on Drug Polymorphs and Solvates,” Polymorphism in Pharmaceutical Solids, vol. 95, pp. 331-361, 1999.
Express-Pharma-Online (http://www.expresspharmaonline.com/20031023/edit02.shtml) 2003.
Notice of Allowance issued for U.S. Appl. No. 11/689,864 on Apr. 10, 2009; AZ Ref. 102218-2 US.

Affiliated with

Also associated with

Rating

Compounds, compositions containing them, preparation thereof... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds, compositions containing them, preparation thereof..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, compositions containing them, preparation thereof... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4136473